These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 717407)

  • 61. Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital.
    Woodward RS; Medoff G; Smith MD; Gray JL
    Am J Med; 1987 Nov; 83(5):817-23. PubMed ID: 3674089
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Developing drug-use profiles from drug-charge records.
    Hlynka JN; Smith WE; Brodie DC
    Am J Hosp Pharm; 1979 Oct; 36(10):1347-51. PubMed ID: 507077
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Drug cost containment at a large teaching hospital.
    Pillans PI; Conry I; Gie BE
    Pharmacoeconomics; 1992 May; 1(5):377-82. PubMed ID: 10147002
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of absorption and excretion of cefazolin with cephalothin and cephapirin.
    Shimizu T
    Jpn J Antibiot; 1975 Aug; 28(4):542-8. PubMed ID: 1160145
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A survey of cephalosporin use. Monitoring use in a hospital setting.
    Arthurson SL; Turnidge JD; Odgers CL
    Med J Aust; 1979 Oct; 2(8):436-9. PubMed ID: 318492
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Drug product selection by formulary committees in Sweden.
    Lilja J
    Am J Hosp Pharm; 1979 Aug; 36(8):1042, 1044. PubMed ID: 484560
    [No Abstract]   [Full Text] [Related]  

  • 67. Effect of control programs on cefazolin prescribing in a teaching hospital.
    Ma MY; Goldstein EJ; Meyer RD
    Am J Hosp Pharm; 1979 Aug; 36(8):1055-8. PubMed ID: 484564
    [No Abstract]   [Full Text] [Related]  

  • 68. Antibiotic cost-containment.
    Huckleberry SD
    Drug Intell Clin Pharm; 1986; 20(7-8):589-91. PubMed ID: 3743415
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antimicrobial surveillance in a VAMC teaching hospital--resulting cost avoidance.
    Powers DA
    Drug Intell Clin Pharm; 1986 Oct; 20(10):803-5. PubMed ID: 3533488
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Is there cost reduction potential for extended half-life cephalosporins?
    Scalley RD; Stuart CC
    Drug Intell Clin Pharm; 1986 Dec; 20(12):975-80. PubMed ID: 3816548
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Selection of cephalosporins for hospital formularies.
    Wilson WR
    Diagn Microbiol Infect Dis; 1995; 22(1-2):129-34. PubMed ID: 7587026
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Reduction in antibiotic costs by restricting use of an oral cephalosporin.
    Seligman SJ
    Am J Med; 1981 Dec; 71(6):941-4. PubMed ID: 7315856
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Formulary conversion of cefoxitin usage to cefotetan: experience at a large teaching hospital.
    Smith KS; Briceland LL; Nightingale CH; Quintiliani R
    DICP; 1989 Dec; 23(12):1024-30. PubMed ID: 2603441
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Influence of cephalosporin antibiotics on blood coagulation and platelet function.
    Natelson EA; Brown CH; Bradshaw MW; Alfrey CP; Williams TW
    Antimicrob Agents Chemother; 1976 Jan; 9(1):91-3. PubMed ID: 1259395
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reducing cephalosporin purchases.
    Mioduch J; Burnakis TG
    Drug Intell Clin Pharm; 1985 Mar; 19(3):211-3. PubMed ID: 3979265
    [No Abstract]   [Full Text] [Related]  

  • 76. Hospital use of antimicrobial drugs. Survey at 19 hospitals and results of antimicrobial control program.
    Craig WA; Uman SJ; Shaw WR; Ramgopal V; Eagan LL; Leopold ET
    Ann Intern Med; 1978 Nov; 89(5 Pt 2 Suppl):793-5. PubMed ID: 717957
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Economic analysis of a new drug: potential savings in hospital operating costs from the use of a once-daily regimen of a parenteral cephalosporin.
    Eisenberg JM; Koffer H; Finkler SA
    Rev Infect Dis; 1984; 6 Suppl 4():S909-23. PubMed ID: 6441226
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hospital formularies: need for continuous intervention.
    Feely J; Chan R; Cocoman L; Mulpeter K; O'Connor P
    BMJ; 1990 Jan; 300(6716):28-30. PubMed ID: 2105122
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Drug formularies--good or evil? The clinical perspective.
    Woodhouse KW
    Cardiology; 1994; 85 Suppl 1():36-40. PubMed ID: 7743533
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparative costs of two cephalosporins, cefazolin and cephalothin.
    Klimek JJ; Cunha BA; Quintiliani R
    Drug Intell Clin Pharm; 1976 Nov; 10(11):655. PubMed ID: 10236221
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.